The First AI Designed Drugs Are in the Clinic: 200 Candidates, Zero Approvals, and the Race to the First FDA Win - June 4, 2026
More than 200 AI discovered drug candidates are now in human trials, yet not one has been approved. We dig into Insilico Medicine's Rentosertib, Relay Therapeutics' Zovegalisib, Eli Lilly's 2.75 billion dollar Insilico deal, and the LillyPod supercomputer to ask whether 2026 through 2028 is the make or break window for the first FDA approval of an AI designed medicine.
Hosted by Chris and Laura.
The DX Today Podcast brings you daily deep dives into the most
consequential stories in the AI ecosystem.
Podden och tillhörande omslagsbild på den här sidan tillhör
Rick Spair. Innehållet i podden är skapat av Rick Spair och inte av,
eller tillsammans med, Poddtoppen.